{"id":9335,"date":"2025-03-14T16:48:14","date_gmt":"2025-03-14T16:48:14","guid":{"rendered":"https:\/\/biotechsa.com\/2\/?p=9335"},"modified":"2025-03-20T00:04:10","modified_gmt":"2025-03-20T00:04:10","slug":"synolis-va-una-alternativa-segura-para-la-osteoartritis-de-rodilla","status":"publish","type":"post","link":"https:\/\/biotechsa.com\/2\/articulos-cientificos\/articulos-synolis-va\/synolis-va-una-alternativa-segura-para-la-osteoartritis-de-rodilla\/","title":{"rendered":"Synolis VA: una alternativa segura para la osteoartritis de rodilla"},"content":{"rendered":"\n<p class=\"\">El Hospital General de Changi (CGH) administra viscosuplementaci\u00f3n para la osteoartritis de rodilla mediante inyecciones intraarticulares de \u00e1cido hialur\u00f3nico, utilizando <strong>Synvisc o Synvisc-One<\/strong>. Sin embargo, algunos pacientes experimentan <strong>reacciones adversas conocidas como <em>\u00falceras <\/em>o artritis seudos\u00e9ptica<\/strong> con tratamientos repetidos. Para estos casos, se propuso <strong>Synolis VA<\/strong> como una alternativa m\u00e1s segura.<\/p>\n\n\n\n<p class=\"\"><strong>Evaluaci\u00f3n y resultados<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"> <strong>Poblaci\u00f3n:<\/strong> Pacientes con osteoartritis de rodilla.<\/li>\n\n\n\n<li class=\"\"> <strong>Intervenci\u00f3n:<\/strong> Synolis VA.<\/li>\n\n\n\n<li class=\"\"> <strong>Comparaci\u00f3n:<\/strong> Synvisc.<\/li>\n\n\n\n<li class=\"\"><strong>Resultados:<\/strong> Evaluaci\u00f3n del riesgo de artritis pseudos\u00e9ptica<\/li>\n<\/ul>\n\n\n\n<p class=\"\"><strong>Evidencia sobre Synolis VA<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\">No se encontraron reportes de reacciones adversas graves.<\/li>\n\n\n\n<li class=\"\">Un estudio postcomercializaci\u00f3n mostr\u00f3 <strong>reducci\u00f3n del dolor y mejor funcionalidad durante 6 meses<\/strong>.<\/li>\n\n\n\n<li class=\"\">En la experiencia de CGH, <strong>ning\u00fan paciente present\u00f3 artritis seusos\u00e9ptica<\/strong> tras el uso de Synolis VA.<\/li>\n<\/ul>\n\n\n\n<p class=\"\">\u26a0\ufe0f <strong>Reacciones adversas con Synvisc<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\">De acuerdo a diversos estudios hay una incidencia que ver\u00eda entre <strong>0.26% y 27%<\/strong>.<\/li>\n\n\n\n<li class=\"\"> En la experiencia de CGH, el <strong>4.7% de los pacientes<\/strong> present\u00f3 reacciones adversas.<\/li>\n<\/ul>\n\n\n\n<p class=\"\"><strong>Conclusi\u00f3n:<\/strong> Dado el riesgo documentado con Synvisc y la ausencia de eventos adversos en la experiencia local, <strong>Synolis VA es una alternativa viable para pacientes con reacciones recurrentes<\/strong>.<\/p>\n\n\n\n<p class=\"\"><strong>Lee el art\u00edculo completo<\/strong>: <a href=\"https:\/\/www.cambridge.org\/core\/journals\/international-journal-of-technology-assessment-in-health-care\/article\/pp042-rapid-health-technology-assessment-no-flare-reaction-with-synolis-va-in-knee-osteoarthritis\/E973AD835D04229535620AF85C190859\" target=\"_blank\" rel=\"noopener\">https:\/\/www.cambridge.org\/core\/journals\/international-journal-of-technology-assessment-in-health-care\/article\/pp042-rapid-health-technology-assessment-no-flare-reaction-with-synolis-va-in-knee-osteoarthritis\/E973AD835D04229535620AF85C190859<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Hospital General de Changi (CGH) administra viscosuplementaci\u00f3n para la osteoartritis de rodilla mediante inyecciones intraarticulares de \u00e1cido hialur\u00f3nico, utilizando Synvisc o Synvisc-One. Sin embargo, algunos pacientes experimentan reacciones adversas [&hellip;]<\/p>\n","protected":false},"author":92,"featured_media":9336,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[162,104],"tags":[108,179,128,109,178],"class_list":["post-9335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articulos-cientificos","category-articulos-synolis-va","tag-acido-hialuronico","tag-dolor","tag-rodilla","tag-synolis-va","tag-synvisc"],"_links":{"self":[{"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/posts\/9335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/users\/92"}],"replies":[{"embeddable":true,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/comments?post=9335"}],"version-history":[{"count":5,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/posts\/9335\/revisions"}],"predecessor-version":[{"id":9347,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/posts\/9335\/revisions\/9347"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/media\/9336"}],"wp:attachment":[{"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/media?parent=9335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/categories?post=9335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biotechsa.com\/2\/wp-json\/wp\/v2\/tags?post=9335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}